Ameriprise Financial Inc. Sells 3,779,734 Shares of Lam Research Corporation $LRCX

Ameriprise Financial Inc. cut its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 11.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,440,197 shares of the semiconductor company’s stock after selling 3,779,734 shares during the quarter. Lam Research comprises 0.7% of Ameriprise Financial Inc.’s portfolio, making the stock its 13th biggest holding. Ameriprise Financial Inc. owned 2.41% of Lam Research worth $2,963,125,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. IMG Wealth Management Inc. bought a new stake in shares of Lam Research during the 2nd quarter worth about $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research in the 2nd quarter valued at $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research in the 2nd quarter valued at $29,000. REAP Financial Group LLC acquired a new position in Lam Research in the 2nd quarter valued at $31,000. Finally, Bank of Jackson Hole Trust increased its position in Lam Research by 111.1% during the 2nd quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock worth $37,000 after buying an additional 200 shares during the period. 84.61% of the stock is owned by institutional investors.

Insider Activity

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 102,608 shares of company stock worth $14,916,496 in the last three months. Corporate insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Lam Research stock opened at $160.52 on Friday. The business has a 50 day moving average of $152.53 and a 200-day moving average of $119.99. The company has a market capitalization of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.73 and a beta of 1.77. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $169.69. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Evercore ISI boosted their target price on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a research report on Thursday, October 23rd. Citigroup upped their target price on Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Morgan Stanley increased their target price on Lam Research from $137.00 to $158.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 2nd. The Goldman Sachs Group boosted their price objective on shares of Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. Finally, TD Cowen raised their target price on Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $152.87.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.